Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.

[1]  J. Matsumura,et al.  Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals. , 2009, Journal of vascular surgery.

[2]  P. Desgranges,et al.  Below the knee , 2009 .

[3]  Seth B. Blattman,et al.  Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. , 2008, Journal of vascular surgery.

[4]  R. Morishita,et al.  Results of a Double-Blind, Placebo-Controlled Study to Assess the Safety of Intramuscular Injection of Hepatocyte Growth Factor Plasmid to Improve Limb Perfusion in Patients With Critical Limb Ischemia , 2008, Circulation.

[5]  N. Shammas,et al.  Preventing Lower Extremity Distal Embolization Using Embolic Filter Protection: Results of the PROTECT Registry , 2008, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[6]  P. Faries,et al.  Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. , 2007, Journal of vascular surgery.

[7]  G. Moneta,et al.  Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. , 2007, Journal of vascular surgery.

[8]  M. Bosiers,et al.  Nitinol stenting for treatment of ''below-the-knee'' critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. , 2007, The Journal of cardiovascular surgery.

[9]  D. Bloch,et al.  Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[10]  W. Hiatt,et al.  Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. , 2007, Journal of vascular surgery.

[11]  Bram D. Zuckerman,et al.  FDA perspective on clinical trial design for femoropopliteal stent correction of peripheral vascular insufficiency cardiovascular devices , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  F. Vermassen,et al.  A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. , 2007, European heart journal.

[13]  L. Norgren,et al.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). , 2007, Journal of vascular surgery.

[14]  G. Grunkemeier,et al.  Prosthetic heart valves: Objective Performance Criteria versus randomized clinical trial. , 2006, The Annals of thoracic surgery.

[15]  Bram D. Zuckerman,et al.  FDA perspective on clinical trial design for cardiovascular devices. , 2006, The Annals of thoracic surgery.

[16]  W. Hiatt,et al.  Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. , 2006, Journal of vascular surgery.

[17]  Scott A Berceli,et al.  Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. , 2006, Journal of vascular surgery.

[18]  D. Scheinert,et al.  Limb Salvage following Laser-Assisted Angioplasty for Critical Limb Ischemia: Results of the LACI Multicenter Trial , 2006, Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists.

[19]  J. Forbes,et al.  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial , 2005, The Lancet.

[20]  G. Moneta,et al.  Design and Rationale of the PREVENT III Clinical Trial: Edifoligide for the Prevention of Infrainguinal Vein Graft Failure , 2005, Vascular and endovascular surgery.

[21]  R. Morishita,et al.  Therapeutic angiogenesis for critical limb ischemia: design of the hepatocyte growth factor therapeutic angiogenesis clinical trial , 2004, Vascular medicine.

[22]  R. Prescott,et al.  Bypass versus angioplasty to treat severe limb ischemia: factors that affect treatment preferences of UK surgeons and interventional radiologists. , 2004, Journal of vascular surgery.

[23]  R. Rutherford,et al.  Recommended standards for reports dealing with lower extremity ischemia: revised version. , 1997, Journal of vascular surgery.